211 related articles for article (PubMed ID: 29117547)
1. A Prostate Cancer Risk Element Functions as a Repressive Loop that Regulates HOXA13.
Luo Z; Rhie SK; Lay FD; Farnham PJ
Cell Rep; 2017 Nov; 21(6):1411-1417. PubMed ID: 29117547
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA HOTTIP contributes to the progression of prostate cancer by regulating HOXA13.
Zhang SR; Yang JK; Xie JK; Zhao LC
Cell Mol Biol (Noisy-le-grand); 2016 Mar; 62(3):84-8. PubMed ID: 27064878
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming Antagonizes the Oncogenicity of HOXA13-Long Noncoding RNA HOTTIP Axis in Gastric Cancer Cells.
Wu DC; Wang SSW; Liu CJ; Wuputra K; Kato K; Lee YL; Lin YC; Tsai MH; Ku CC; Lin WH; Wang SW; Kishikawa S; Noguchi M; Wu CC; Chen YT; Chai CY; Lin CS; Kuo KK; Yang YH; Miyoshi H; Nakamura Y; Saito S; Nagata K; Lin CS; Yokoyama KK
Stem Cells; 2017 Oct; 35(10):2115-2128. PubMed ID: 28782268
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Quagliata L; Matter MS; Piscuoglio S; Arabi L; Ruiz C; Procino A; Kovac M; Moretti F; Makowska Z; Boldanova T; Andersen JB; Hämmerle M; Tornillo L; Heim MH; Diederichs S; Cillo C; Terracciano LM
Hepatology; 2014 Mar; 59(3):911-23. PubMed ID: 24114970
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
Xiao S; Song B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
[TBL] [Abstract][Full Text] [Related]
6. CTCF boundary remodels chromatin domain and drives aberrant
Luo H; Wang F; Zha J; Li H; Yan B; Du Q; Yang F; Sobh A; Vulpe C; Drusbosky L; Cogle C; Chepelev I; Xu B; Nimer SD; Licht J; Qiu Y; Chen B; Xu M; Huang S
Blood; 2018 Aug; 132(8):837-848. PubMed ID: 29760161
[No Abstract] [Full Text] [Related]
7. Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.
Wang SS; Wuputra K; Liu CJ; Lin YC; Chen YT; Chai CY; Lin CS; Kuo KK; Tsai MH; Wang SW; Chen KK; Miyoshi H; Nakamura Y; Saito S; Hanafusa T; Wu DC; Lin CS; Yokoyama KK
Oncotarget; 2016 Jun; 7(24):36049-36064. PubMed ID: 27144338
[TBL] [Abstract][Full Text] [Related]
8. HOTTIP and HOXA13 are oncogenes associated with gastric cancer progression.
Chang S; Liu J; Guo S; He S; Qiu G; Lu J; Wang J; Fan L; Zhao W; Che X
Oncol Rep; 2016 Jun; 35(6):3577-85. PubMed ID: 27108607
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells.
Lin C; Wang Y; Wang Y; Zhang S; Yu L; Guo C; Xu H
Oncogene; 2017 Sep; 36(38):5392-5406. PubMed ID: 28534516
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.
Li Z; Zhao X; Zhou Y; Liu Y; Zhou Q; Ye H; Wang Y; Zeng J; Song Y; Gao W; Zheng S; Zhuang B; Chen H; Li W; Li H; Li H; Fu Z; Chen R
J Transl Med; 2015 Mar; 13():84. PubMed ID: 25889214
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
Jin HJ; Jung S; DebRoy AR; Davuluri RV
Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
[TBL] [Abstract][Full Text] [Related]
12. Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.
Gao P; Xia JH; Sipeky C; Dong XM; Zhang Q; Yang Y; Zhang P; Cruz SP; Zhang K; Zhu J; Lee HM; Suleman S; Giannareas N; Liu S; ; Tammela TLJ; Auvinen A; Wang X; Huang Q; Wang L; Manninen A; Vaarala MH; Wang L; Schleutker J; Wei GH
Cell; 2018 Jul; 174(3):576-589.e18. PubMed ID: 30033361
[TBL] [Abstract][Full Text] [Related]
13. High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models.
Quagliata L; Quintavalle C; Lanzafame M; Matter MS; Novello C; di Tommaso L; Pressiani T; Rimassa L; Tornillo L; Roncalli M; Cillo C; Pallante P; Piscuoglio S; Ng CK; Terracciano LM
Lab Invest; 2018 Jan; 98(1):95-105. PubMed ID: 29035381
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration.
Cheng Y; Jutooru I; Chadalapaka G; Corton JC; Safe S
Oncotarget; 2015 May; 6(13):10840-52. PubMed ID: 25912306
[TBL] [Abstract][Full Text] [Related]
15. Psip1/p52 regulates posterior Hoxa genes through activation of lncRNA Hottip.
Pradeepa MM; McKenna F; Taylor GC; Bengani H; Grimes GR; Wood AJ; Bhatia S; Bickmore WA
PLoS Genet; 2017 Apr; 13(4):e1006677. PubMed ID: 28384324
[TBL] [Abstract][Full Text] [Related]
16. TWIST1-WDR5-
Malek R; Gajula RP; Williams RD; Nghiem B; Simons BW; Nugent K; Wang H; Taparra K; Lemtiri-Chlieh G; Yoon AR; True L; An SS; DeWeese TL; Ross AE; Schaeffer EM; Pienta KJ; Hurley PJ; Morrissey C; Tran PT
Cancer Res; 2017 Jun; 77(12):3181-3193. PubMed ID: 28484075
[TBL] [Abstract][Full Text] [Related]
17. Opposing Roles for the lncRNA Haunt and Its Genomic Locus in Regulating HOXA Gene Activation during Embryonic Stem Cell Differentiation.
Yin Y; Yan P; Lu J; Song G; Zhu Y; Li Z; Zhao Y; Shen B; Huang X; Zhu H; Orkin SH; Shen X
Cell Stem Cell; 2015 May; 16(5):504-16. PubMed ID: 25891907
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA HOTTIP cooperates with CCCTC-binding factor to coordinate HOXA gene expression.
Wang F; Tang Z; Shao H; Guo J; Tan T; Dong Y; Lin L
Biochem Biophys Res Commun; 2018 Jun; 500(4):852-859. PubMed ID: 29698677
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops.
Guo Y; Perez AA; Hazelett DJ; Coetzee GA; Rhie SK; Farnham PJ
Genome Biol; 2018 Oct; 19(1):160. PubMed ID: 30296942
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer.
Jiang H; Xiong W; Chen L; Lv Z; Yang C; Li Y
J Cell Biochem; 2019 Jun; 120(6):8965-8974. PubMed ID: 30809864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
